Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?

The Alarming Pivot: How Telehealth Giants Are Trading Patient Access for Pharmaceutical Profits

Unlocking Autism's Enigma: NIH Launches Groundbreaking Data Science Initiative with a Focus on Exposomics

Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings

Biotech's Q4 Reckoning: Navigating the Storm, Charting the Future

Unveiling the Maternal Research Gap: Why Pregnant Women Need to Be Included in Clinical Trials

The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines

Healthcare's Brink: How a Government Shutdown Threatens HHS, CDC, and FDA

The Mind Behind Miracles: Daniel Skovronsky's Blueprint for Eli Lilly's R&D Revolution

Unveiling the Shadowy Ethics: Former Pharma CEO's FDA Claims Spark Regulatory Outcry

STAT+: Mayo Clinic partners with supercomputing startup Cerebras to build custom AI tools

STAT+: Sen. Sanders, others lawmakers open probe into asthma inhaler makers over pricing, patent maneuvers

STAT+: CVS Health sees Medicare Advantage patients seek more care, eating into profits

STAT+: At JPM, Bristol’s new CEO appeals to history to try to soothe investors’ nerves

STAT+: The ADC hot streak continues: J&J to buy cancer drug developer Ambrx Biopharma